Reuters logo
8 months ago
BRIEF-Neos Therapeutics says completes resubmission NDA for Cotempla XR-ODT
December 20, 2016 / 12:56 PM / 8 months ago

BRIEF-Neos Therapeutics says completes resubmission NDA for Cotempla XR-ODT

Dec 20 (Reuters) - Neos Therapeutics Inc

* Neos Therapeutics completes resubmission of NDA for Cotempla XR-ODT for the treatment of ADHD

* If approved, expect to sell ADHD products by end of 2017 alongside Adzenys XR-ODT Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below